The Venture Leaders, as members of the Swiss National Startup Team, have a clear goal: they see themselves as global players and seek to fuel their global expansion. The ten entrepreneurs in this year’s selection had the opportunity to practice their pitches for their promising medtech startups in front of a distinguished audience at the Investor and Business Development Roadshow in the Boston area. The week-long trip provided a deep dive into the global medical technology scene and included presentation sessions, high-level networking opportunities, workshops and individual business development activities.
Boston is one of the world’s leading life sciences hubs and the perfect springboard for ambitious startups on their way to global expansion. By building a strong network during a week full of pitches, expert workshops and inspiration, entrepreneurs will be able to accelerate their international growth. Participating startup founders returned to Switzerland with helpful, first-hand insights from U.S. investors, new insights into cultural differences to consider when raising funds overseas, and knowledge and skills. dedicated expert advice covering all aspects of entering the US market.
Swiss medtech startups engage investors in Boston and Cambridge, USA
The Venture Leaders Medtech roadshow offered a week-long dive into the life sciences ecosystem for the founders of aiEndoscopic, Arbrea Laboratories, ArcoScreen, b-rayZ, keep the mind, EarlySight, MOMM Diagnosis, Oncobit, REA Diagnosisand TWICE. Joining the 2022 cohort was Gora Conley, CEO and co-founder of Annaidawho was selected to the 2020 team, but whose roadshow had to be delayed due to the pandemic.
The roadshow included investor presentations, workshops and feedback sessions with Richard Anders of Mass Med Angels; Vinit Nijhawan of MassVentures; Edward Melia, Managing Partner at Evolution Global Growth Partners; Julien Pham, GP Founder at 3CC Third Culture Capital; and Tal Wenderow, Venture Partner at Genesis Medtech Group. Swissnex Boston held a presentation on the US regulatory process for the Swiss National Startup Team with Mark Lesselroth, President and CEO of BioPortUSA. Participants were not only able to build a strong network in Boston, but also among themselves as part of a team of entrepreneurs who shared similar goals and challenges.
“The Venture Leaders program is a great entry point to network in the US life sciences and venture capital ecosystem. Thanks to the excellent team dynamics, there has been an exchange of lively experiences among other entrepreneurs, which will certainly continue beyond the program.”
— Mathias Wipf, CEO and co-founder of MOMM Diagnostics
Beyond the investor meetings, the founders deepened their knowledge with a valuable MedScience Venture panel at Swissnex headquarters and with a pitch training session entitled “Get Your Startup Story Straight: The Definitive Storytelling Framework for Innovators and Entrepreneurs” directed by Bret Siarkowski and Christopher Ford of MedScience Ventures. In addition, Helbling technique gave an informative presentation on the development and industrialization of medical products.
“Being part of Venture Leaders gave us a great introduction to the Boston startup ecosystem. We were a great group and the interactions within the team and with local startups were very helpful. potential investors and I have many contacts to follow to better plan our market entry.”
— Claudia Scheckel, CEO of Oncobit and captain of the Swiss National Startup Team
At the Medtech Pitch Cruize Pitchfest organized by Swissnex Boston, each Medtech Venture Leader presented their project alongside Boston-based startups representing American talent in a friendly competition. Congratulations to Claudia Scheckel from Oncobit, who was chosen by the public as the big winner of the evening! MedTech Pitch Cruize award includes free registration to MedTech Conference 2022 in Boston October 24-26, 2022, plus guaranteed entry to the AdvaMed Accel Leadership Seminar on the first day of the conference, courtesy of AdvaMed.
“The Venture Leaders roadshow was an exceptional opportunity to make initial contacts in the Boston ecosystem. During this period, we received feedback from several leading players that helped us improve our go-to-market strategy. in the market in the United States. I highly recommend it to all medtech start-ups.”
— Philippe Ganz, CEO of aiEndoscopic
The participating sponsors were once again enthusiastic in their support of the Swiss National Startup Team. Nicolas Mosimann from Kellerhals Carrard shared his thoughts: “Venture Leaders Medtech is a unique opportunity for entrepreneurs to promote their startup in America, enrich their network and perfect their pitches. It is one of those essential initiatives for the Swiss ecosystem of startups.”
Jordi Montserrat, Managing Partner of Venturelab, says this year’s medtech roadshow was a resounding success: “It was great to be back in presidential mode, allowing for direct interactions. Feedback from investors and partners was very positive, and I’m sure we’re going to hear a lot more about these startups in the future.”
Venturelab has been organizing international roadshows for Swiss National Startup Teams for 17 years. Ambitious entrepreneurs and their promising startups are introduced to top investors and potential clients in top tech hubs such as Silicon Valley, Boston, New York, London, Munich, Shanghai, Beijing, Shenzhen and Barcelona.
The Venture Leaders Medtech program is organized by Venturelab and supported by ETH Lausanne, ETH ZürichHansjörg Wyss, Helbling technique, Kellerhals Carrard, Paul Scherrer Institute, Swissnex Boston, Canton of Vaud, Canton of Zürichand Venture Leader alumnus Dominik Lysek.
Learn more about the Medtech Venture Leaders 2022 startups below:
The current scarcity and projected shortage of skilled healthcare workers is increasingly causing problems in experience-based tasks, such as endoscopy. aiE combines artificial intelligence… Read more
We develop cutting-edge technology, based on visual computing and AI, to create digital human avatars from mobile devices. The main line of business is the preview of joint surgery… Read more
ArcoScreen SA, a spin-off from EPFL (Ecole Polytechnique Fédérale de Lausanne), was founded in July 2021 and has developed a new cell membrane receptor screening platform based on microfluoric reading systems… Read more
b-rayZ develops artificial intelligence software for quality management and standardization of procedures in radiology. We help radiologists provide better care with lower operating costs. Read more
At Bearmind, we protect professional and recreational gamers from the lifelong trauma of brain injury. Bearmind SA is an EPFL spin-off that develops and markets services to help sports clubs… Read more
EarlySight aims to reduce vision loss by enabling effective detection and better monitoring of eye diseases. The company is developing a high-performance ocular imaging instrument that allows physicians to see… Read more
MOMM develops high sensitivity rapid diagnostic tests. Our technology combines the commercial advantage of lateral flow immunoassays, with the sensitivity of ELISA and reader simplicity similar to that of blood… Read more
Oncobit is a MedTech spin-off from the University of Zurich, developing precision diagnostic and monitoring tests for personalized cancer care. Oncobits products aim to provide a detailed understanding… Read more
Rea is developing a wearable accessory, in the form of a sanitary napkin, that tracks biochemical markers of preterm birth (PTB). Our solution allows physicians to continuously monitor pregnant women at risk of PTB for … Read more
Every year, 250,000 people suffer a spinal cord injury resulting in permanent paraplegia. TWIICE is a modular and customizable walking aid exoskeleton that allows paraplegics to adapt to the… Read more